EP2597951A2 - USE OF SUCCINATE DEHYDROGENASE INHIBITORS AND/OR RESPIRATORY CHAIN COMPLEX III INHIBITORS FOR IMPROVING THE RATIO OF HARMFUL TO BENEFICIAL MICROORGANISMS